Insilico Medicine Heads To JP Morgan Healthcare Conference
Leadership from Insilico Medicine is set to attend the 42nd Annual JP Morgan Healthcare Conference in San Francisco from January…
Leadership from Insilico Medicine is set to attend the 42nd Annual JP Morgan Healthcare Conference in San Francisco from January…
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and BCL-2 and p53 prevents the progression of HCC…